About the Reports

The reports below outline the impact that medical indications have on driving. The reports include an evidence report - a systematic review of research literature on specific questions regarding medical conditions and driving - as well as a report from the Medical Expert Panel (MEP), an independent panel of physicians, clinicians and scientists who are experts in their field. The MEP reviews the evidence in the research report about a question or topic, and submits opinions to the Agency.

Reports

• Seizure Disorder and Medical Certification of Commercial Motor Vehicle Driver Safety (2019)
  • Full Evidence Report
     
• Implantable Cardio Defibrillators and the Impact of a Shock to the Patient when Deployed (2014)
  • Research White Paper
     
• Medical Examiner Physical Qualification Standards and Clinical Guidelines for Cardiovascular Disease and Commercial Motor Vehicle Driver Safety (2013)
  • Expert Panel Opinion
     
• Cochlear Implants and CMV Driver Safety (2011)
  • Full Evidence Report
     
• Obstructive Sleep Apnea and CMV Driver Safety (2011)
  • Full Evidence Report
    ​
• Diabetes and CMV Driver Safety (2011)
  • Full Evidence Report
    ​
• Traumatic Brain Injury (2010)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Stroke (2009)
  • Executive Summary | Expert Panel Opinion
    ​
• Multiple Sclerosis and Parkinson's Disease (2009)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Psychiatric Disease (2008)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Seizure Disorders (2007)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Sleep Disorders (2007)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
     
• Renal Disease (2007)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Musculoskeletal Disease (2007)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Hearing (2007)
  • Executive Summary | Full Evidence Report
     
• Diabetes Mellitus (Endocrine Disease) (2006)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
    ​
• Schedule II Licit Medications (2006)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion
     
• Cardiovascular Disease (2006)
  • Executive Summary | Full Evidence Report | Expert Panel Opinion

Disclaimer: FMCSA considers evidence, expert recommendations, and other data; however, all proposed changes to current standards and guidance will be subject to public notice-and-comment and regulatory processes.